Sign in to view content

Single Intraoperative Subconjunctival Triamcinolone Acetonide Injection Versus 4-6-Week Topical Steroid Taper Following Vitreore

Elizabeth A Atchison, MD

Video
Published 2018

Related

Assessing Characteristics of Patients With or Without Intraocular Inflammation (IOI) In the Brolucizumab Treatment Arms From the HAWK and HARRIER, Phase 3 Studies
Jeffrey S. Heier, MD
Updates from the Field
2020
Abicipar Phase 2 MAPLE Trial Supports Improved Safety for Patients with nAMD Following a Modified Manufacturing Process
Raj K. Maturi, MD
Updates from the Field
2019
Commercial OCT Enters the Cellular Age – Tracking Macrophage Surveillance of the Macula Circulation!
Richard B. Rosen, MD, DSc(Hon), FACS, FASRS, FARVO
Annual Meeting Talks
2021

Category: Pharmacology

Inflammation

See more